Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ersi decoction
- Development stage
- Preclinical
- Administration
- Oral
01
Overview
Ersi decoction is a Traditional Chinese Medicine (TCM) decoction. Its specific composition and detailed mechanism of action are not clearly identified in publicly available literature under this exact name. It has been investigated in clinical studies, serving as a control group in a trial for rheumatoid arthritis. Due to the lack of specific information, its precise pharmacological properties remain largely undocumented.
- Other names
- 二四汤
Beyond the preview
Go deeper on Ersi decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ersi decoction.